🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to provide continued treatment with eltromb...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-10-15
Trial ID
NCT01957176
Treatments Being Tested
This was a non-randomized, open-label, phase II study to assess the efficac...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-23
Trial ID
NCT02148133
Treatments Being Tested
The purpose of this project is to describe the pathophysiology of thrombocy...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2009-06
Trial ID
NCT00909363
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of eltrom...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-11
Trial ID
NCT02998645
Treatments Being Tested
This was an open-label Phase III extension study to evaluate the long-term ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06-18
Trial ID
NCT02201290
Treatments Being Tested
This was an open label, non-randomized, phase II study of eltrombopag in co...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-12
Trial ID
NCT02404025
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of eltrombopag m...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2021-05-25
Trial ID
NCT04797000
Treatments Being Tested
Inherited thrombocytopenias (ITs) are a heterogeneous group of disorders ch...
Status
Completed
Location
Department of Internal Medicine, Hospital of Padova
Start Date
2015-04
Trial ID
NCT02422394
Treatments Being Tested
The purpose of this trial was to assess the ability of eltrombopag to induc...
Status
Completed
Location
Hematology Oncology Association of Rockland
Start Date
2018-11-02
Trial ID
NCT03524612
Treatments Being Tested
This is an open label, multi-centre, dose ranging study to assess efficacy,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01
Trial ID
NCT00861601
Treatments Being Tested